melagatran has been researched along with chromozym th in 1 studies
| Studies (melagatran) | Trials (melagatran) | Recent Studies (post-2010) (melagatran) | Studies (chromozym th) | Trials (chromozym th) | Recent Studies (post-2010) (chromozym th) |
|---|---|---|---|---|---|
| 185 | 32 | 19 | 45 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bodendiek, I; Bruhn, HD; Lentz, S; Seeger, M | 1 |
1 other study(ies) available for melagatran and chromozym th
| Article | Year |
|---|---|
[Chromogenic substrate as antidote against the thrombin inhibitor Melagatran?].
Topics: Antidotes; Antithrombins; Azetidines; Benzylamines; Chromogenic Compounds; Glycine; Humans; Oligopeptides | 2003 |